Incyte Corp. (INCY)
121.70
-0.57
(-0.47%)
USD |
NASDAQ |
Nov 12, 16:00
121.74
+0.04
(+0.03%)
Pre-Market: 08:26
Incyte Shareholders Equity (Quarterly) : 5.643B for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 5.643B |
| June 30, 2026 | 6.344B |
| March 31, 2026 | 5.623B |
| December 31, 2025 | 5.167B |
| September 30, 2025 | 4.651B |
| June 30, 2025 | 4.171B |
| March 31, 2025 | 3.668B |
| December 31, 2024 | 3.448B |
| September 30, 2024 | 3.171B |
| June 30, 2024 | 2.997B |
| March 31, 2024 | 5.394B |
| December 31, 2023 | 5.190B |
| September 30, 2023 | 4.931B |
| June 30, 2023 | 4.741B |
| March 31, 2023 | 4.463B |
| December 31, 2022 | 4.370B |
| September 30, 2022 | 4.227B |
| June 30, 2022 | 4.085B |
| March 31, 2022 | 3.863B |
| December 31, 2021 | 3.770B |
| September 30, 2021 | 3.149B |
| June 30, 2021 | 2.936B |
| March 31, 2021 | 2.728B |
| December 31, 2020 | 2.611B |
| September 30, 2020 | 2.391B |
| Date | Value |
|---|---|
| June 30, 2020 | 2.345B |
| March 31, 2020 | 1.938B |
| December 31, 2019 | 2.598B |
| September 30, 2019 | 2.423B |
| June 30, 2019 | 2.247B |
| March 31, 2019 | 2.086B |
| December 31, 2018 | 1.926B |
| September 30, 2018 | 1.803B |
| June 30, 2018 | 1.733B |
| March 31, 2018 | 1.628B |
| December 31, 2017 | 1.631B |
| September 30, 2017 | 1.758B |
| June 30, 2017 | 1.027B |
| March 31, 2017 | 965.93M |
| December 31, 2016 | 419.47M |
| September 30, 2016 | 369.99M |
| June 30, 2016 | 297.06M |
| March 31, 2016 | 227.75M |
| December 31, 2015 | 171.16M |
| September 30, 2015 | 88.74M |
| June 30, 2015 | 55.17M |
| March 31, 2015 | -41.41M |
| December 31, 2014 | -81.63M |
| September 30, 2014 | -89.59M |
| June 30, 2014 | -171.00M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 33.50B |
| Mirum Pharmaceuticals, Inc. | -54.19M |
| AbbVie, Inc. | -4.583B |
| Alnylam Pharmaceuticals, Inc. | 3.604B |
| Biogen, Inc. | 18.92B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.287B |
| Total Liabilities (Quarterly) | 1.644B |
| Debt to Equity Ratio | 0.0066 |
| Current Ratio | 3.840 |
| Net Debt Paydown Yield | 0.00% |